NOFER, JERZY ROCH
Distribuzione geografica
| Continente | # |
|---|---|
| NA - Nord America | 196 |
| EU - Europa | 151 |
| AS - Asia | 50 |
| OC - Oceania | 2 |
| SA - Sud America | 1 |
| Totale | 400 |
| Nazione | # |
|---|---|
| US - Stati Uniti d'America | 195 |
| DE - Germania | 99 |
| CN - Cina | 38 |
| ES - Italia | 28 |
| GB - Regno Unito | 9 |
| IT - Italia | 5 |
| IE - Irlanda | 4 |
| IN - India | 4 |
| AU - Australia | 2 |
| FR - Francia | 2 |
| TR - Turchia | 2 |
| VN - Vietnam | 2 |
| AT - Austria | 1 |
| CA - Canada | 1 |
| CL - Cile | 1 |
| HK - Hong Kong | 1 |
| JP - Giappone | 1 |
| RO - Romania | 1 |
| RU - Federazione Russa | 1 |
| SA - Arabia Saudita | 1 |
| SI - Slovenia | 1 |
| TW - Taiwan | 1 |
| Totale | 400 |
| Città | # |
|---|---|
| Fairfield | 29 |
| Houston | 27 |
| Woodbridge | 25 |
| Sopelana | 19 |
| Nürnberg | 16 |
| Ann Arbor | 14 |
| Cambridge | 12 |
| Seattle | 12 |
| Buffalo | 10 |
| Santa Cruz | 8 |
| Wuhan | 7 |
| Chongqing | 5 |
| Wilmington | 5 |
| Ashburn | 4 |
| Beijing | 4 |
| Des Moines | 4 |
| Leawood | 4 |
| Shanghai | 4 |
| Dublin | 3 |
| Hangzhou | 3 |
| Modena | 3 |
| Chengdu | 2 |
| Chicago | 2 |
| Dong Ket | 2 |
| Guangzhou | 2 |
| Henderson | 2 |
| Istanbul | 2 |
| Las Vegas | 2 |
| Mountain View | 2 |
| Paris | 2 |
| Silver Spring | 2 |
| Bellevue | 1 |
| Berlin | 1 |
| Bethesda | 1 |
| Boulder | 1 |
| Central District | 1 |
| Clearwater | 1 |
| Coventry | 1 |
| Dallas | 1 |
| Easton | 1 |
| Feltham | 1 |
| Guilin | 1 |
| Hefei | 1 |
| Hillsborough | 1 |
| Homburg | 1 |
| Jinan | 1 |
| Kansas City | 1 |
| Lake Forest | 1 |
| Los Angeles | 1 |
| Nanjing | 1 |
| New York | 1 |
| North Brunswick | 1 |
| Novokuznetsk | 1 |
| Phoenix | 1 |
| Providence | 1 |
| Provo | 1 |
| Reggio Emilia | 1 |
| Riva | 1 |
| Saarbrücken | 1 |
| San Diego | 1 |
| Sans Souci | 1 |
| Santiago | 1 |
| Segrate | 1 |
| Shenyang | 1 |
| Sonseca | 1 |
| Taipei | 1 |
| Toronto | 1 |
| University Park | 1 |
| Worcester | 1 |
| Totale | 276 |
| Nome | # |
|---|---|
| Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R-/-) mice., file e31e124b-3020-987f-e053-3705fe0a095a | 412 |
| Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice, file e31e124e-90e8-987f-e053-3705fe0a095a | 1 |
| Totale | 413 |
| Categoria | # |
|---|---|
| all - tutte | 527 |
| article - articoli | 0 |
| book - libri | 0 |
| conference - conferenze | 0 |
| curatela - curatele | 0 |
| other - altro | 0 |
| patent - brevetti | 0 |
| selected - selezionate | 0 |
| volume - volumi | 0 |
| Totale | 527 |
| Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018/2019 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 8 |
| 2019/2020 | 139 | 11 | 18 | 17 | 12 | 18 | 20 | 9 | 5 | 10 | 10 | 3 | 6 |
| 2020/2021 | 109 | 26 | 3 | 7 | 5 | 4 | 7 | 25 | 7 | 11 | 6 | 7 | 1 |
| 2021/2022 | 111 | 12 | 7 | 16 | 20 | 15 | 2 | 9 | 3 | 5 | 2 | 14 | 6 |
| 2022/2023 | 36 | 0 | 3 | 5 | 4 | 3 | 6 | 7 | 2 | 3 | 2 | 1 | 0 |
| Totale | 413 | ||||||||||||